
Zihai Li, MD, PhD
@zihai
Founding Director, Pelotonia Institute for Immuno-Oncology (@OhioStatePIIO) • Deputy Director of @OSUCCC_James for Translational Research • Views My Own
ID: 52736312
https://cancer.osu.edu/piio 01-07-2009 14:16:05
4,4K Tweet
2,2K Takipçi
713 Takip Edilen

A subset of tumor-associated NK cells restricts checkpoint blockade sensitivity by impeding a ROR-α–dependent cytotoxic CD8 T-cell differentiation program via competition for IFNα & IL-2 Cancer Discovery Zihai Li, MD, PhD aacrjournals.org/cancerdiscover…








ICYMI: Vaccines in cancer treatment and prevention: the time is now: jci.org/articles/view/… In this viewpoint, William Becker & Kimryn Rathmell suggest that cutting‑edge mRNA neoantigen-based vaccines can train the immune system to better detect and eliminate cancer cells.




Very pleased to host Mengze Lyu during his visit to Pelotonia Institute for Immuno-Oncology.



Kudos to the international team from 🇨🇳 & 🇺🇸 that conducted this important study published in Cancer Cell Brain metastases are one of most dreaded complications of advanced disease. Pan-cancer human brain metastases atlas at single-cell resolution cell.com/cancer-cell/ab…





Inspired choices recognizing excellence in immunology all around!!! Jeff Rathmell ❤️

BREAKING: We uncovered a potent immune alliance that could change how we treat solid tumors. Published in Cancer Cell , we show that Th17 cells *must* work with B cells to eliminate tumors—and keep it from coming back. 📄 cell.com/cancer-cell/fu… 🧵1/12👇Let’s walk through it:
